VolitionRX Limited (VNRX) vs Vivos Therapeutics, Inc. (VVOS)

VolitionRX Limited and Vivos Therapeutics, Inc. are both Medical Devices companies. VolitionRX Limited is the larger, with a market value of $6.9M against $4.9M — 1.4× the size. VolitionRX Limited grew revenue faster over the last twelve months: 86.3% against 45.2%. Vivos Therapeutics, Inc. has the higher net margin (−121.8% vs −1,043.1%) and the lower return on invested capital (−592.7% vs 0.00%). Across the 17 metrics below, Vivos Therapeutics, Inc. leads on 10 and VolitionRX Limited on 7.

Valuation

Metric VNRX VVOS Medical Devices median
P/E n/m n/m 22.18
P/S 0.97 0.12 2.70
P/B n/m n/m 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 4.31 0.42 2.38
Earnings yield (1,469.23%) (1,357.14%) (8.22%)
Free cash flow yield (835.24%) (768.05%) (7.80%)

Profitability

Metric VNRX VVOS Medical Devices median
Gross margin 100.00% 61.89% 56.01%
Operating margin (790.20%) (107.89%) (15.03%)
Net margin (1,043.08%) (121.79%) (20.40%)
Free cash flow margin (796.73%) (90.97%) (7.24%)
Return on equity 76.95% 10,022.05% (15.32%)
Return on assets (301.54%) (101.46%) (19.72%)
Return on invested capital 0.00% (592.70%) (10.33%)

Growth

Metric VNRX VVOS Medical Devices median
Revenue growth (TTM) 86.32% 45.21% 8.80%
EPS growth (last fiscal year) 29.03% 6.76% —
Revenue growth, 5-year CAGR 164.28% 5.95% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric VNRX VVOS Medical Devices median
Debt to equity (0.33) (2.04) 0.07
Current ratio 0.30 0.21 2.50
Net debt to EBITDA (0.52) (0.37) 0.49

Dividend

Metric VNRX VVOS Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric VNRX VVOS Medical Devices median
Market cap 6.92m 4.94m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack